192 related articles for article (PubMed ID: 28546105)
1. Ex vivo skin permeation and penetration of nonivamide from and in vivo skin tolerability of film-forming formulations containing porous silica.
Heck R; Lukić MŽ; Savić SD; Daniels R; Lunter DJ
Eur J Pharm Sci; 2017 Aug; 106():34-40. PubMed ID: 28546105
[TBL] [Abstract][Full Text] [Related]
2. Film-forming formulations containing porous silica for the sustained delivery of actives to the skin.
Heck R; Hermann S; Lunter DJ; Daniels R
Eur J Pharm Biopharm; 2016 Nov; 108():1-8. PubMed ID: 27553263
[TBL] [Abstract][Full Text] [Related]
3. In vitro skin permeation and penetration of nonivamide from novel film-forming emulsions.
Lunter D; Daniels R
Skin Pharmacol Physiol; 2013; 26(3):139-46. PubMed ID: 23549242
[TBL] [Abstract][Full Text] [Related]
4. In vitro studies on release and skin permeation of nonivamide from novel oil-in-oil-emulsions.
Rottke M; Lunter DJ; Daniels R
Eur J Pharm Biopharm; 2014 Feb; 86(2):260-6. PubMed ID: 24095781
[TBL] [Abstract][Full Text] [Related]
5. Methods for the determination of the substantivity of topical formulations.
Herrmann S; Daniels R; Lunter D
Pharm Dev Technol; 2017 Jun; 22(4):487-491. PubMed ID: 26754018
[TBL] [Abstract][Full Text] [Related]
6. Method to determine the impact of substantivity on ex vivo skin-permeation.
Schmidberger M; Daniels R; Lunter DJ
Eur J Pharm Biopharm; 2018 Oct; 131():1-7. PubMed ID: 30048744
[TBL] [Abstract][Full Text] [Related]
7. In vitro topical application and in vivo pharmacodynamic evaluation of nonivamide hydrogels using Wistar rat as an animal model.
Fang JY; Leu YL; Wang YY; Tsai YH
Eur J Pharm Sci; 2002 Jun; 15(5):417-23. PubMed ID: 12036718
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo evaluations of topically applied capsaicin and nonivamide from hydrogels.
Wang YY; Hong CT; Chiu WT; Fang JY
Int J Pharm; 2001 Aug; 224(1-2):89-104. PubMed ID: 11472818
[TBL] [Abstract][Full Text] [Related]
9. Effect of hydrophilic and hydrophobic polymers on permeation of S-amlodipine besylate through intercalated polymeric transdermal matrix: 3(2) designing, optimization and characterization.
Rastogi V; Yadav P; Husain A; Verma A
Drug Dev Ind Pharm; 2019 Apr; 45(4):669-682. PubMed ID: 30633579
[TBL] [Abstract][Full Text] [Related]
10. New film forming emulsions containing Eudragit® NE and/or RS 30D for sustained dermal delivery of nonivamide.
Lunter DJ; Daniels R
Eur J Pharm Biopharm; 2012 Oct; 82(2):291-8. PubMed ID: 22750130
[TBL] [Abstract][Full Text] [Related]
11. A New Approach to Ex Vivo Permeation Studies in In-Situ Film-Forming Systems.
Silva-Alvarez AF; Ferreira MP; Vicentini FTMC; Pedrazzi V; de Freitas O
AAPS PharmSciTech; 2020 Sep; 21(7):257. PubMed ID: 32895787
[TBL] [Abstract][Full Text] [Related]
12. Formulation design and in vitro ex vivo evaluation of transdermal patches of Cinnarizine.
Yamsani VV; Mudulaghar MK; Afreen S; Wajid S; Ravula SK; Babelghaith SD
Pak J Pharm Sci; 2017 Nov; 30(6):2075-2083. PubMed ID: 29175776
[TBL] [Abstract][Full Text] [Related]
13. Transdermal delivery of sodium nonivamide propionate by iontophoresis.
Fang JY; Kuo CT; Huang YB; Wu PC; Tsai YH
Biol Pharm Bull; 1998 Oct; 21(10):1117-20. PubMed ID: 9821823
[TBL] [Abstract][Full Text] [Related]
14. Development of novel formulations to enhance in vivo transdermal permeation of tocopherol.
Nada AH; Zaghloul AA; Hedaya MM; Khattab IS
Acta Pharm; 2014 Sep; 64(3):299-309. PubMed ID: 25296676
[TBL] [Abstract][Full Text] [Related]
15. Influence of the Component Excipients on the Quality and Functionality of a Transdermal Film Formulation.
Saoji SD; Atram SC; Dhore PW; Deole PS; Raut NA; Dave VS
AAPS PharmSciTech; 2015 Dec; 16(6):1344-56. PubMed ID: 25922089
[TBL] [Abstract][Full Text] [Related]
16. Electrically-assisted skin permeation of two synthetic capsaicin derivatives, sodium nonivamide acetate and sodium nonivamide propionate, via rate-controlling polyethylene membranes.
Fang JY; Huang YB; Wang HY; Tsai YH
Biol Pharm Bull; 2005 Sep; 28(9):1695-701. PubMed ID: 16141542
[TBL] [Abstract][Full Text] [Related]
17. Topical delivery of lipophilic drugs from o/w Pickering emulsions.
Frelichowska J; Bolzinger MA; Pelletier J; Valour JP; Chevalier Y
Int J Pharm; 2009 Apr; 371(1-2):56-63. PubMed ID: 19135516
[TBL] [Abstract][Full Text] [Related]
18. Development and evaluation of transdermal patches of nonivamide and sodium nonivamide acetate.
Wu PC; Fang JY; Huang YB; Tsai YH
Pharmazie; 1997 Feb; 52(2):135-8. PubMed ID: 9122272
[TBL] [Abstract][Full Text] [Related]
19. Using ordered mesoporous silica SBA-15 to limit cutaneous penetration and transdermal permeation of organic UV filters.
Daneluti ALM; Neto FM; Ruscinc N; Lopes I; Robles Velasco MV; Do Rosário Matos J; Baby AR; Kalia YN
Int J Pharm; 2019 Oct; 570():118633. PubMed ID: 31437563
[TBL] [Abstract][Full Text] [Related]
20. Development of ciclopirox olamine topical formulations: evaluation of drug release, penetration and cutaneous retention.
Pinheiro VA; Serikaku D; Baby AR; Velasco MV; Kaneko TM; Consiglieri VO
Pharm Dev Technol; 2015 Mar; 20(2):197-203. PubMed ID: 24286179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
